oncology

Checkpoint inhibitors may cause irAE in many cancer patients

Immune checkpoint inhibitors (ICI)  have been linked with a high rate of immune related adverse events (irAE) in cancer patients. Smokers and patients of older age were found to be at particular risk, suggests an analysis led by Dr Margaret M. Byrne, a haematologist and oncologist at Tufts Medical Center in the US, and published ...

Already a member?

Login to keep reading.


OR
© 2022 the limbic